These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons. Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741 [TBL] [Abstract][Full Text] [Related]
9. AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models. Gumusgoz E; Kasiri S; Guisso DR; Wu J; Dear M; Verhalen B; Minassian BA Neurotherapeutics; 2022 Apr; 19(3):982-993. PubMed ID: 35347645 [TBL] [Abstract][Full Text] [Related]
11. Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. Valles-Ortega J; Duran J; Garcia-Rocha M; Bosch C; Saez I; Pujadas L; Serafin A; Cañas X; Soriano E; Delgado-García JM; Gruart A; Guinovart JJ EMBO Mol Med; 2011 Nov; 3(11):667-81. PubMed ID: 21882344 [TBL] [Abstract][Full Text] [Related]
12. Accumulation of Laforin and Other Related Proteins in Canine Lafora Disease With EPM2B Repeat Expansion. Chambers JK; Thongtharb A; Shiga T; Azakami D; Saito M; Sato M; Morozumi M; Nakayama H; Uchida K Vet Pathol; 2018 Jul; 55(4):543-551. PubMed ID: 29444631 [TBL] [Abstract][Full Text] [Related]